Cargando…
A comprehensive map of human glucokinase variant activity
BACKGROUND: Glucokinase (GCK) regulates insulin secretion to maintain appropriate blood glucose levels. Sequence variants can alter GCK activity to cause hyperinsulinemic hypoglycemia or hyperglycemia associated with GCK-maturity-onset diabetes of the young (GCK-MODY), collectively affecting up to 1...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131484/ https://www.ncbi.nlm.nih.gov/pubmed/37101203 http://dx.doi.org/10.1186/s13059-023-02935-8 |
_version_ | 1785031188075773952 |
---|---|
author | Gersing, Sarah Cagiada, Matteo Gebbia, Marinella Gjesing, Anette P. Coté, Atina G. Seesankar, Gireesh Li, Roujia Tabet, Daniel Weile, Jochen Stein, Amelie Gloyn, Anna L. Hansen, Torben Roth, Frederick P. Lindorff-Larsen, Kresten Hartmann-Petersen, Rasmus |
author_facet | Gersing, Sarah Cagiada, Matteo Gebbia, Marinella Gjesing, Anette P. Coté, Atina G. Seesankar, Gireesh Li, Roujia Tabet, Daniel Weile, Jochen Stein, Amelie Gloyn, Anna L. Hansen, Torben Roth, Frederick P. Lindorff-Larsen, Kresten Hartmann-Petersen, Rasmus |
author_sort | Gersing, Sarah |
collection | PubMed |
description | BACKGROUND: Glucokinase (GCK) regulates insulin secretion to maintain appropriate blood glucose levels. Sequence variants can alter GCK activity to cause hyperinsulinemic hypoglycemia or hyperglycemia associated with GCK-maturity-onset diabetes of the young (GCK-MODY), collectively affecting up to 10 million people worldwide. Patients with GCK-MODY are frequently misdiagnosed and treated unnecessarily. Genetic testing can prevent this but is hampered by the challenge of interpreting novel missense variants. RESULT: Here, we exploit a multiplexed yeast complementation assay to measure both hyper- and hypoactive GCK variation, capturing 97% of all possible missense and nonsense variants. Activity scores correlate with in vitro catalytic efficiency, fasting glucose levels in carriers of GCK variants and with evolutionary conservation. Hypoactive variants are concentrated at buried positions, near the active site, and at a region of known importance for GCK conformational dynamics. Some hyperactive variants shift the conformational equilibrium towards the active state through a relative destabilization of the inactive conformation. CONCLUSION: Our comprehensive assessment of GCK variant activity promises to facilitate variant interpretation and diagnosis, expand our mechanistic understanding of hyperactive variants, and inform development of therapeutics targeting GCK. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-02935-8. |
format | Online Article Text |
id | pubmed-10131484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101314842023-04-27 A comprehensive map of human glucokinase variant activity Gersing, Sarah Cagiada, Matteo Gebbia, Marinella Gjesing, Anette P. Coté, Atina G. Seesankar, Gireesh Li, Roujia Tabet, Daniel Weile, Jochen Stein, Amelie Gloyn, Anna L. Hansen, Torben Roth, Frederick P. Lindorff-Larsen, Kresten Hartmann-Petersen, Rasmus Genome Biol Research BACKGROUND: Glucokinase (GCK) regulates insulin secretion to maintain appropriate blood glucose levels. Sequence variants can alter GCK activity to cause hyperinsulinemic hypoglycemia or hyperglycemia associated with GCK-maturity-onset diabetes of the young (GCK-MODY), collectively affecting up to 10 million people worldwide. Patients with GCK-MODY are frequently misdiagnosed and treated unnecessarily. Genetic testing can prevent this but is hampered by the challenge of interpreting novel missense variants. RESULT: Here, we exploit a multiplexed yeast complementation assay to measure both hyper- and hypoactive GCK variation, capturing 97% of all possible missense and nonsense variants. Activity scores correlate with in vitro catalytic efficiency, fasting glucose levels in carriers of GCK variants and with evolutionary conservation. Hypoactive variants are concentrated at buried positions, near the active site, and at a region of known importance for GCK conformational dynamics. Some hyperactive variants shift the conformational equilibrium towards the active state through a relative destabilization of the inactive conformation. CONCLUSION: Our comprehensive assessment of GCK variant activity promises to facilitate variant interpretation and diagnosis, expand our mechanistic understanding of hyperactive variants, and inform development of therapeutics targeting GCK. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-02935-8. BioMed Central 2023-04-26 /pmc/articles/PMC10131484/ /pubmed/37101203 http://dx.doi.org/10.1186/s13059-023-02935-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Gersing, Sarah Cagiada, Matteo Gebbia, Marinella Gjesing, Anette P. Coté, Atina G. Seesankar, Gireesh Li, Roujia Tabet, Daniel Weile, Jochen Stein, Amelie Gloyn, Anna L. Hansen, Torben Roth, Frederick P. Lindorff-Larsen, Kresten Hartmann-Petersen, Rasmus A comprehensive map of human glucokinase variant activity |
title | A comprehensive map of human glucokinase variant activity |
title_full | A comprehensive map of human glucokinase variant activity |
title_fullStr | A comprehensive map of human glucokinase variant activity |
title_full_unstemmed | A comprehensive map of human glucokinase variant activity |
title_short | A comprehensive map of human glucokinase variant activity |
title_sort | comprehensive map of human glucokinase variant activity |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131484/ https://www.ncbi.nlm.nih.gov/pubmed/37101203 http://dx.doi.org/10.1186/s13059-023-02935-8 |
work_keys_str_mv | AT gersingsarah acomprehensivemapofhumanglucokinasevariantactivity AT cagiadamatteo acomprehensivemapofhumanglucokinasevariantactivity AT gebbiamarinella acomprehensivemapofhumanglucokinasevariantactivity AT gjesinganettep acomprehensivemapofhumanglucokinasevariantactivity AT coteatinag acomprehensivemapofhumanglucokinasevariantactivity AT seesankargireesh acomprehensivemapofhumanglucokinasevariantactivity AT liroujia acomprehensivemapofhumanglucokinasevariantactivity AT tabetdaniel acomprehensivemapofhumanglucokinasevariantactivity AT weilejochen acomprehensivemapofhumanglucokinasevariantactivity AT steinamelie acomprehensivemapofhumanglucokinasevariantactivity AT gloynannal acomprehensivemapofhumanglucokinasevariantactivity AT hansentorben acomprehensivemapofhumanglucokinasevariantactivity AT rothfrederickp acomprehensivemapofhumanglucokinasevariantactivity AT lindorfflarsenkresten acomprehensivemapofhumanglucokinasevariantactivity AT hartmannpetersenrasmus acomprehensivemapofhumanglucokinasevariantactivity AT gersingsarah comprehensivemapofhumanglucokinasevariantactivity AT cagiadamatteo comprehensivemapofhumanglucokinasevariantactivity AT gebbiamarinella comprehensivemapofhumanglucokinasevariantactivity AT gjesinganettep comprehensivemapofhumanglucokinasevariantactivity AT coteatinag comprehensivemapofhumanglucokinasevariantactivity AT seesankargireesh comprehensivemapofhumanglucokinasevariantactivity AT liroujia comprehensivemapofhumanglucokinasevariantactivity AT tabetdaniel comprehensivemapofhumanglucokinasevariantactivity AT weilejochen comprehensivemapofhumanglucokinasevariantactivity AT steinamelie comprehensivemapofhumanglucokinasevariantactivity AT gloynannal comprehensivemapofhumanglucokinasevariantactivity AT hansentorben comprehensivemapofhumanglucokinasevariantactivity AT rothfrederickp comprehensivemapofhumanglucokinasevariantactivity AT lindorfflarsenkresten comprehensivemapofhumanglucokinasevariantactivity AT hartmannpetersenrasmus comprehensivemapofhumanglucokinasevariantactivity |